Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,794 | -8,908 | -7,360 | -12,452 | -8,994 |
| Depreciation Amortization | 72 | 67 | 81 | 70 | 53 |
| Income taxes - deferred | N/A | N/A | N/A | -1,621 | N/A |
| Accounts payable and accrued liabilities | -81 | 259 | 39 | -608 | -246 |
| Other Working Capital | -327 | -213 | -523 | -530 | 434 |
| Other Operating Activity | 328 | 150 | 243 | 5,627 | 993 |
| Operating Cash Flow | $-8,802 | $-8,645 | $-7,520 | $-9,514 | $-7,760 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 5,500 |
| PPE Investments | -19 | -72 | -5 | -203 | -4 |
| Net Acquisitions | N/A | N/A | N/A | 100 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -150 |
| Investing Cash Flow | $-19 | $-72 | $-5 | $-103 | $5,346 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 231 | N/A | N/A | N/A | N/A |
| Debt Repayment | -27 | -6 | N/A | N/A | N/A |
| Common Stock Issued | 15,944 | 781 | 18,823 | 292 | 10,203 |
| Common Stock Repurchased | -15 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -2 | -3 | 0 | 0 | 0 |
| Financing Cash Flow | $16,131 | $772 | $18,823 | $292 | $10,203 |
| Beginning Cash Position | 6,984 | 14,929 | 3,631 | 12,956 | 5,167 |
| End Cash Position | 14,294 | 6,984 | 14,929 | 3,631 | 12,956 |
| Net Cash Flow | $7,310 | $-7,945 | $11,298 | $-9,325 | $7,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,802 | -8,645 | -7,520 | -9,514 | -7,760 |
| Capital Expenditure | -19 | -72 | -5 | -203 | -4 |
| Free Cash Flow | -8,821 | -8,717 | -7,525 | -9,717 | -7,764 |